Treventis attends 4th Zebrafish for Personalized & Precision Medicine Conference
Treventis was represented at the 4th Zebrafish for Personalized & Precision Medicine Conference, running from Sep 18-20, 2019, in Toronto, Ontario. In attendance was VP Research Marcia Taylor, who chaired one of the symposia. The main objective of the conference is to apply research knowledge in zebrafish to applications that would allow for so-called ‘humanized’ […]
Treventis founders present research at AAIC 2019
Treventis was well represented at the Alzheimer Association International Conference, running from Jul 14-18, 2019, in Los Angeles, California. In attendance were CEO Christopher Barden, VP Research Marcia Taylor, and Chief Medical Officer Dr. Donald Weaver. Dr. Weaver presented a poster entitled “Efficient Computational Algorithms for Predicting Brain Permeability and Effect of Transporters.” In this […]
Treventis attends the BIO International Convention, gives ‘Buzz of BIO’ presentation
Treventis attended the BIO International Convention that took place on June 3-6 in Philadelphia, Pennsylvania, with more than 16,000 attendees passionate about creating new opportunities to partner and collaborate on innovative drug projects aimed at improving the lives of patients. This year, Treventis was a “Buzz of BIO” competition finalist and was invited to speak […]
Treventis attends AD/PD 2019
Treventis scientists attended the 14th International Conference on Alzheimer’s & Parkinson’s Diseases and Related Neurological Disorders held on March 26-31 in Lisbon, Portugal. This conference focuses on the most current findings in understanding pathogenesis mechanisms, as well as new clinical strategies and treatments of AD and PD. During the conference visit, it became apparent that […]
Treventis adds to Scientific Advisory Board
FEB 22, 2019 – Treventis is pleased to announce that internationally recognized ALS researcher Dr. Janice Robertson has joined its Scientific Advisory Board. Dr. Robertson, a Canada Research Chair in Amyotrophic Lateral Sclerosis and a Ontario Premier Research Excellence awardee, is Professor at the Tanz Centre for Research in Neurodegenerative Diseases and of the Department […]
Treventis attends the 7th World CNS Summit
CSO Mark Reed attended the 7th World CNS Summit in Boston, Massachusetts. This industry-focused event is aimed at fostering translational neurodegenerative research and inspiring drug discovery for neurodegenerative disorders. Dr. Reed spoke with companies in the neurodegenerative space about the Treventis approach to protein misfolding therapeutics.
Treventis founder Sultan Darvesh presents invited CANP lecture
Dr. Sultan Darvesh, neurologist, medicinal chemist, and Treventis founder was as an invited lecturer to the 58th annual Canadian Association of Neuropathogists (CANP), held in Halifax, Nova Scotia on October 4, 2018. Dr. Darvesh delivered a lecture entitled “Butyrylcholinesterase as a Biomarker for Alzheimer’s Disease” in which he explained the neuropathology of butyrylcholinesterase. He also […]
Treventis founder Sultan Darvesh elected to Canadian Academy of Health Sciences
Treventis founder Dr. Sultan Darvesh was elected a Fellow of the Canadian Academy of Health Sciences at an induction ceremony on Sep 13, 2018, in Vancouver, British Columbia. The citation for this prestigious honor reads: “Induction into the CAHS as a Fellow is considered one of the highest honours within Canada’s academic community. CAHS Fellows, […]
Treventis scientists attend Alzheimer Association International Conference
Treventis was well represented at the Alzheimer Association International Conference, running from Jul 22-26, 2018, in Chicago, Illinois. In attendance were CEO Christopher Barden; CSO Mark Reed; Chief Medical Officer Dr. Donald Weaver, and Treventis Diagnostics head Dr. Sultan Darvesh. Dr. Weaver presented a poster entitled “Optimization of a Murine CNS IDO1 Pharmacokinetic-Pharmacodynamic Model Using […]
Treventis Diagnostics highlighted in recent press articles
The Treventis diagnostics program, headed by neurologist and medicinal chemist Dr. Sultan Darvesh, was recently featured in two news articles: http://www.nshealth.ca/news/creating-worlds-first-definitive-diagnostic-test-alzheimers-disease https://www.dal.ca/news/2018/01/10/sultan-darvesh–revolutionary-researcher.html?utm_source=Today@Dal&utm_medium=email&utm_campaign=dalnews